SCHEMBL18820428

SCHEMBL18820428

CC(C)c1ccc2c(n1)CN(C(C)(C)C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21414336 0.80 DRD2 (0.33) —
SCHEMBL19498162 0.77 CYP1A2 (0.32) —
SCHEMBL16639804 0.75 DRD2 (0.34) —
SCHEMBL19498567 0.75 ABHD6 (0.43) —
SCHEMBL19498186 0.72 NCF1 (0.38) —
SCHEMBL19498187 0.72 DRD2 (0.37) —
SCHEMBL23103392 0.71 MAOA (0.43) —
SCHEMBL20203638 0.71 CYP2C9 (0.44) —
SCHEMBL21414393 0.71 PDCD1 (0.35) —
SCHEMBL20203493 0.70 MAPT (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828373-B2 2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-11-28 — — US disclosed
US-20170121323-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE DERIVATIVES AS CDK INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-05-04 — — US disclosed
Send feedback